Pharmaceutical

Rohto Pharmaceutical gets grant for ophthalmic composition for treating myopia with crocetin and ginkgo leaf

Discover Rohto Pharmaceutical's patented ophthalmic composition with crocetin and ginkgo leaf extract, proven to prevent and treat myopia in all ages. Explore the groundbreaking method for treating axial myopia and ocular diseases.

Mar 30, 2024 - 00:00
Discover Rohto Pharmaceutical's patented ophthalmic composition with crocetin and ginkgo leaf extract, proven to prevent and treat myopia in all ages. Explore the groundbreaking method for treating axial myopia and ocular diseases.
Read the original article

Tags:

Previous Article

Angelini gets grant for method for labelling reels using robot and application r...

Next Article

PTC Therapeutics gets grant for treatment of huntington’s disease using compound...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

IBA venture PanTera gains €134m in funding to scale up actinium-225 production

IBA venture PanTera gains €134m in funding to scale up ...

Sep 12, 2024

After FDA nod, Better Therapeutics races to boost dwindling cash

After FDA nod, Better Therapeutics races to boost dwind...

Jul 14, 2023

Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter

Back to school for biotech, Biogen’s potential pivot, &...

Sep 8, 2023